Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions.

about

Structure-guided evolution of a 2-phenyl-4-carboxyquinoline chemotype into PPARα selective agonists: New leads for oculovascular conditions.

Item

http://www.wikidata.org/entity/Q52599996

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Structure-guided evolution of ...... for oculovascular conditions.

@en

Structure-guided evolution of ...... for oculovascular conditions.

@nl

type

Item

label

Structure-guided evolution of ...... for oculovascular conditions.

@en

Structure-guided evolution of ...... for oculovascular conditions.

@nl

prefLabel

Structure-guided evolution of ...... for oculovascular conditions.

@en

Structure-guided evolution of ...... for oculovascular conditions.

@nl

P1476

Structure-guided evolution of ...... s for oculovascular conditions

@en

P2093

Adam S Duerfeldt

http://www.w3.org/2001/XMLSchema#string

Jian-Xing Ma

http://www.w3.org/2001/XMLSchema#string

Xiao-Zheng Dou

http://www.w3.org/2001/XMLSchema#string

Younghwa Shin

http://www.w3.org/2001/XMLSchema#string

P2860

Diabetic Retinopathy: Animal Models, Therapies, and Perspectives

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

Substituted 2-[(4-aminomethyl)phenoxy]-2-methylpropionic acid PPARalpha agonists. 1. Discovery of a novel series of potent HDLc raising agents

Discovery of an oxybenzylglycine based peroxisome proliferator activated receptor alpha selective agonist 2-((3-((2-(4-chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic acid (BMS-687453)

Molecular mechanism of peroxisome proliferator-activated receptor α activation by WY14643: a new mode of ligand recognition and receptor stabilization

The mechanisms of action of PPARs

Fenofibrate - a potential systemic treatment for diabetic retinopathy?

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

The PPARs: from orphan receptors to drug discovery

Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.

P304

2717-2722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BMCL.2018.03.010

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Dinesh Nath

P577

2018-04-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29628329

http://www.w3.org/2001/XMLSchema#string

P932

6119630

http://www.w3.org/2001/XMLSchema#string